Riskpilot← Back to searchSign inGet full accessSpecialisthuset i Halmstad AB
ABActiveOrg 5568793623Brogatan 42 2trMedical specialists activities · NACE 8622Est. 20122 employees
Revenue 2024
SEK 3,3M
-1% vs 2023
EBITDA margin
11.6%
-27% vs 2023
Equity ratio
77.2%
Financial strength
Net profit 2024
SEK 295K
-21% vs 2023
| Revenue | SEK 3,3M | -1% |
| EBITDA | SEK 385K | -27% |
| Net profit | SEK 295K | -21% |
| Total assets | SEK 1,5M | +1% |
| Equity | SEK 1,1M | +0% |
| Employees | 2 | — |
Legal name
Specialisthuset i Halmstad AB
Org number
5568793623
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
2 januari 2012
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva specialistläkarverksamhet, utbildning och ledarskapsutveckling inom hälso- och sjukvård. Därtill äga och förvalta fast och lös egendom samt handel med värdepapper och därmed förenlig verksamhet.
Address
Brogatan 42 2tr
Email
anettelundh11@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 675 | 2 504 | 2 942 | 3 332 | 3 311 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 681 | 415 | 565 | 528 | 385 |
| Depreciation & amort. | −171 | −99 | −52 | −64 | −12 |
| EBIT | 510 | 316 | 513 | 464 | 373 |
| Net financials | −1 | −1 | −1 | 5 | — |
| Profit before tax | 509 | 315 | 512 | 469 | 373 |
| Tax | −109 | −68 | −106 | −96 | −78 |
| Net profit | 400 | 247 | 406 | 373 | 295 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 155 | 1 246 | 1 340 | 1 454 | 1 469 |
| Equity | 910 | 958 | 1 066 | 1 139 | 1 134 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 245 | 289 | 273 | 314 | 335 |
| Total debt | 245 | 289 | 273 | 314 | 335 |
EBITDA margin
11.6%
This company
15.8%
Market median
-27% vs market
20202024
Equity ratio
77.2%
This company
38.2%
Market median
+102% vs market
20202024
Return on equity
26.0%
This company
18.4%
Market median
+41% vs market
20202024
Net profit margin
8.9%
This company
8.1%
Market median
+10% vs market
20202024
Asset turnover
2.25×
This company
1.12×
Market median
+101% vs market
20202024
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Specialisthuset i Halmstad AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Anette Lundh | Chief Executive Officer | 0 companies |
| Jan Staffan Lennart Månsson | Deputy Board Member | 0 companies |